 |
 |
PDF
Direct Evidence that Bevacizumab, an Anti-VEGF Antibody, Up-regulates SDF1 , CXCR4,...
Xu et al. Cancer Res.2009;
69:
7905-7910
|
|
|
|
|
| To view this item, select one of the options below: |
|
|
|
 |
Sign In |
|
|
|
|
|
|
Purchase Short-Term Access |
|
 |
Pay per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00. |
|
|
SitePass - You may access all content in Cancer Research Online (from the computer you are currently using) for 24 hours for US$50.00. |
|
|
|
Regain Access - You can regain access to a recent Pay per Article or SitePass purchase if your access period has not yet expired. |
|
|
|
|
Sign Up |
|
|
Subscribe to the Journal - Subscribe to the print and/or online journal. |
|
|
|
|
